Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Acorda Therapeutics
Acorda Therapeutics
Relatively Low Operating Margin Detected in Shares of BioMarin Pharmaceutical in the Biotechnology Industry (BMRN, SUPG, ACOR, CPHD, GHDX)
Investor's Business Daily
Sun, 10/9/11 - 03:51 pm
Biomarin
Supergen
Acorda Therapeutics
Cepheid
Genomic Health
7 Possible Biotech Takeover Targets
Seeking Alpha
Sun, 09/18/11 - 12:02 pm
Human Genome Sciences
Vertex Pharmaceuticals
Lexicon Pharmaceuticals
Amarin
Exelixis
Dendreon
Acorda Therapeutics
10 Biotech Stocks Being Dumped By Big Money Managers
Seeking Alpha
Tue, 08/30/11 - 08:36 am
Acorda Therapeutics
Albany Molecular Research
Arena Pharmaceuticals
Dyax
Cephalon
Charles River Laboratories
Nektar
Questcor Pharmaceuticals
Vanda
QLT
3 Undervalued Biotechs With Buyout Potential
Seeking Alpha
Wed, 08/3/11 - 11:08 am
Biogen Idec
Abbott Laboratories
Elan
Adeona
Acorda Therapeutics
M&A
Acorda Therapeutics narrows 2nd quarter loss as Amprya sales, expenses climb
Yahoo/AP
Mon, 08/1/11 - 10:29 am
Acorda Therapeutics
earnings
10 Biotech Takeover/LBO Targets With Bullish Options Sentiment
Seeking Alpha
Thu, 07/21/11 - 12:21 pm
M&A
Chelsea Therapeutics
Amgen
Human Genome Sciences
Acorda Therapeutics
Celgene
Dendreon
InterMune
Biomarin
Alnylam
Exelixis
5 Biotech Drug-Launch Stocks to Watch
TheStreet.com
Mon, 07/18/11 - 10:03 am
Human Genome Sciences
Vertex Pharmaceuticals
Acorda Therapeutics
Dendreon
Avanir
lupus
Benlysta
Incivek
hepatitis C
MS
AMPYRA
Provenge
prostate cancer
Nuedexta
PBA
5 Biotech Takeover / LBO Targets With Bullish Short Trends
Seeking Alpha
Sat, 07/16/11 - 11:39 am
Exelixis
InterMune
Dendreon
Savient
Acorda Therapeutics
July Catalysts for Biotech and Drug Stocks
Minyanville
Tue, 07/5/11 - 09:58 am
Seattle Genetics
Bristol-Myers Squibb
JNJ
advisory panels
FDA
Transcept
AstraZeneca
GSK
Human Genome Sciences
Merck
Theravance
Amgen
Biogen Idec
Acorda Therapeutics
Acorda licenses rights to neurological candidate from Medtronic
Fri, 07/1/11 - 06:02 pm
Acorda Therapeutics
license
Medtronic
7 Rallying Biotech Stocks With Conservative Accounting Practices
Seeking Alpha
Fri, 07/1/11 - 09:56 am
Acorda Therapeutics
Incyte
Chelsea Therapeutics
Regeneron
Spectrum Pharmaceuticals
Jazz Pharmaceuticals
Neurocrine
Acorda Pushes Sales of MS Drug
Minyanville
Wed, 06/29/11 - 12:07 am
Acorda Therapeutics
MS
multiple sclerosis
AMPYRA
3 Ways to Play Biotech With Options
Motley Fool
Tue, 06/14/11 - 08:05 pm
Amarin
SIGA technologies
Acorda Therapeutics
Orexigen
Vivus
Analyst raises Acorda target as Ampyra sales grow
Yahoo/AP
Mon, 06/13/11 - 06:11 pm
AMPYRA
Acorda Therapeutics
MS
Biogen Idec
multiple sclerosis
7 Dirt-Cheap Takeover Targets in Biotech
Seeking Alpha
Fri, 06/3/11 - 10:44 am
M&A
Acorda Therapeutics
Antares
Alnylam
BioSante
Catalyst
Inhibitex
Keryx
The Big Winner of the EU Drug Approval Bonanza
Motley Fool
Sat, 05/21/11 - 11:05 am
Benlysta
Human Genome Sciences
Vibativ
Theravance
GSK
Victrelis
Merck
Xgeva
Amgen
Yervoy
Bristol-Myers Squibb
Fampyra
Acorda Therapeutics
Biogen Idec
Three Likely Biotech Acquisition Targets
CNBC
Mon, 04/18/11 - 04:57 pm
M&A
biotech
Human Genome Sciences
Acorda Therapeutics
Forest Labs
Acorda Posts Profit, Outlook
Yahoo/Zacks
Sat, 02/19/11 - 11:32 am
Acorda Therapeutics
Acorda, Biogen fall on EU drug rejection
Marketwatch
Fri, 01/21/11 - 10:13 am
Acorda Therapeutics
Europe
Biogen Idec
Fampyra
MS
multiple sclerosis
Novartis MS Pill Wins European Backing as Rival Acorda Rejected
Bloomberg
Fri, 01/21/11 - 10:11 am
Novartis
MS
multiple sclerosis
Europe
Acorda Therapeutics
Gilenya
Merck KGaA
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »